J
Jian Wang
Researcher at Guangzhou Medical University
Publications - 1831
Citations - 76717
Jian Wang is an academic researcher from Guangzhou Medical University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 94, co-authored 1018 publications receiving 57783 citations. Previous affiliations of Jian Wang include Northwestern University & Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
Measurement of femoral posterior condylar offset and posterior tibial slope in normal knees based on 3D reconstruction
TL;DR: In this article, the posterior condylar offset (PCO) and posterior tibial slope (PTS) were measured and analyzed, as well as the correlation between them.
Posted ContentDOI
PALM-Seq: integrated sequencing of cell-free long RNA and small RNA
Xi Yang,Taifu Wang,Sujun Zhu,Juan Zeng,Yanru Xing,Qing Zhou,Zhongzhen Liu,Haixiao Chen,Jinghua Sun,Liqiang Li,Jinjin Xu,Chunyu Geng,Xun Xu,Jian Wang,Huanming Yang,Shida Zhu,Fang Chen,Wen-Jing Wang +17 more
TL;DR: PALM-Seq provides an integrated, cost-effective and simple method to characterize the landscape of cell- free RNA, and can stimulate further progress in cell-free RNA study and usage.
Journal ArticleDOI
Disease causing poverty: adapting the Onyx and Bullen social capital measurement tool for China.
TL;DR: The Chinese health version of the Onyx-Bullen general social capital scale showed an adequate reliability and validity in a rural disease-causing poverty subpopulation in Shandong province, providing the first general, robust, consistent and reliable measure of social capital in China.
Journal ArticleDOI
Established pulmonary hypertension in rats was reversed by a combination of a HIF-2α antagonist and a p53 agonist.
Qiuyu Zheng,Qiuyu Zheng,Wenju Lu,Han Yan,Xin Duan,Yuqin Chen,Chenting Zhang,Xiaoyun Luo,Jiyuan Chen,Chao Wang,Shiyun Liu,Yi Li,Haiyang Tang,Shamin Rahimi,Shayan Rahimi,Jason X.-J. Yuan,Nanshan Zhong,Kai Yang,Jian Wang,Jian Wang +19 more
TL;DR: In this paper, a combined treatment of Nutlin3a and HIF-2α antagonist, PT2385, was investigated for pulmonary hypertension (PH) based on the cell type-divergent regulation of p53 in pulmonary arterial smooth muscle cells and endothelial cells.
Journal ArticleDOI
The impact of COVID-19 on the cascade of care of HCV in the US and China
Yee Hui Yeo,Xu-Wen Gao,Jian Wang,Qingyun Li,Xiaoming Sun,Yu Geng,Rui Huang,Chao Wu,Fanpu Ji,Vinay Sundaram,Mazen Noureddin,Maria Buti,Walid S. Ayoub +12 more
TL;DR: In this paper , the authors investigated the impact of the COVID-19 pandemic on the care continuum of HCV-infected patients in the US and China, and found that the proportion of patients undergoing HCV RNA testing during DAA treatment decreased from >81.7% before pandemic to 67.8% during the pandemic (P=0.006).